ReWalk Robotics (RWLK) Reports Q4 Loss of $0.10/Share

Go back to ReWalk Robotics (RWLK) Reports Q4 Loss of $0.10/Share

ReWalk Robotics Reports Fourth Quarter 2018 Financial Results

February 8, 2019 7:00 AM EST

2018 total revenue of $6.5 million and $1.6 million during the fourth quarter of 2018 Preparing for 2019 commercial launch of ReStore for stroke patients

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Feb. 08, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (ReWalk or the Company) today announced its financial results for the three- and twelve-months ended December 31, 2018.

Highlights of and subsequent to the fourth quarter of 2018 include:

Completed enrollment in the clinical study of the ReStore soft exo-suit for stroke patients:  On track to file a 510(k) submission with the U.S. Food and Drug... More